Details
New insights into the heart-kidney connection in ATTR-CM.
Dr. Jeffrey Testani and I discuss new analyses showing that acoramidis was associated with early and sustained kidney-protective effects in patients with ATTR-CM—findings that may help explain the therapy's early cardiovascular benefits and offer new perspectives on cardiorenal health.
https://lnkd.in/eGr4gQuN
Supported by an independent educational grant from BridgeBio Inc.